CMH PREF Stock Overview
A medical technology company, engages in the development of products and solutions for neurostimulation treatment in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Chordate Medical Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 4.00 |
| 52 Week High | SEK 6.00 |
| 52 Week Low | SEK 2.50 |
| Beta | 1.67 |
| 1 Month Change | 28.21% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 26.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| CMH PREF | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 22.0% | 7.2% | 3.5% |
| 1Y | n/a | -17.0% | -2.5% |
Return vs Industry: Insufficient data to determine how CMH PREF performed against the Swedish Medical Equipment industry.
Return vs Market: Insufficient data to determine how CMH PREF performed against the Swedish Market.
Price Volatility
| CMH PREF volatility | |
|---|---|
| CMH PREF Average Weekly Movement | 35.6% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in SE Market | 13.7% |
| 10% least volatile stocks in SE Market | 4.2% |
Stable Share Price: CMH PREF's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: Insufficient data to determine CMH PREF's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 3 | Anders Weilandt | www.chordate.com |
Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for neurostimulation treatment in Sweden. It offers Ozilia, a neuromodulation and medication-free treatment technology for chronic migraine and chronic rhinitis. The company was founded in 2005 and is based in Kista, Sweden.
Chordate Medical Holding AB (publ) Fundamentals Summary
| CMH PREF fundamental statistics | |
|---|---|
| Market cap | SEK 24.40m |
| Earnings (TTM) | -SEK 27.25m |
| Revenue (TTM) | SEK 2.44m |
10.0x
P/S Ratio-0.9x
P/E RatioIs CMH PREF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CMH PREF income statement (TTM) | |
|---|---|
| Revenue | SEK 2.44m |
| Cost of Revenue | SEK 454.42k |
| Gross Profit | SEK 1.99m |
| Other Expenses | SEK 29.24m |
| Earnings | -SEK 27.25m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 23, 2025
| Earnings per share (EPS) | -10.10 |
| Gross Margin | 81.40% |
| Net Profit Margin | -1,115.59% |
| Debt/Equity Ratio | 0% |
How did CMH PREF perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/15 15:34 |
| End of Day Share Price | 2025/05/15 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Chordate Medical Holding AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.